
Maintenance BCG Therapy in Korea
Treatment Overview Maintenance BCG (Bacillus Calmette-Guérin) therapy is an advanced immunotherapy for non-muscle invasive bladder cancer (NMIBC) that follows initial BCG induction therapy. This approach
Relieve bladder inflammation and manage chronic conditions with Korea’s advanced bladder instillation therapy. Specialists administer therapeutic solutions directly into the bladder to treat interstitial cystitis, infections, and other urinary tract disorders. Korea Beauty Guide connects international patients with trusted urology clinics providing precise, personalized care for effective symptom relief and long-term bladder health.

Treatment Overview Maintenance BCG (Bacillus Calmette-Guérin) therapy is an advanced immunotherapy for non-muscle invasive bladder cancer (NMIBC) that follows initial BCG induction therapy. This approach

Treatment Overview Sequential intravesical therapy is an advanced treatment strategy for non-muscle invasive bladder cancer (NMIBC) in which patients receive a combination of different intravesical

Treatment Overview Epirubicin bladder instillation is a targeted intravesical chemotherapy treatment for non-muscle invasive bladder cancer (NMIBC). The chemotherapeutic agent epirubicin is delivered directly into

Treatment Overview Doxorubicin intravesical therapy is an effective localized chemotherapy treatment for non-muscle invasive bladder cancer (NMIBC). In this procedure, doxorubicin, a potent anti-cancer drug,

Treatment Overview Gemcitabine bladder instillation is an advanced intravesical chemotherapy treatment used to manage non-muscle invasive bladder cancer (NMIBC), especially for patients who are unresponsive

Treatment Overview Mitomycin C bladder instillation is a targeted intravesical chemotherapy treatment used for non-muscle invasive bladder cancer (NMIBC). In this procedure, the anti-cancer drug

Treatment Overview Bacillus Calmette-Guérin (BCG) therapy is a cornerstone immunotherapy for non-muscle invasive bladder cancer (NMIBC). It involves instilling a weakened strain of Mycobacterium bovis

Treatment Overview Intravesical chemotherapy is a targeted treatment for bladder cancer, in which anti-cancer drugs are delivered directly into the bladder through a catheter. This

Treatment Overview Maintenance BCG (Bacillus Calmette-Guérin) therapy is an advanced immunotherapy for non-muscle invasive bladder cancer (NMIBC) that follows initial BCG induction therapy. This approach

Treatment Overview Sequential intravesical therapy is an advanced treatment strategy for non-muscle invasive bladder cancer (NMIBC) in which patients receive a combination of different intravesical

Treatment Overview Epirubicin bladder instillation is a targeted intravesical chemotherapy treatment for non-muscle invasive bladder cancer (NMIBC). The chemotherapeutic agent epirubicin is delivered directly into

Treatment Overview Doxorubicin intravesical therapy is an effective localized chemotherapy treatment for non-muscle invasive bladder cancer (NMIBC). In this procedure, doxorubicin, a potent anti-cancer drug,

Treatment Overview Gemcitabine bladder instillation is an advanced intravesical chemotherapy treatment used to manage non-muscle invasive bladder cancer (NMIBC), especially for patients who are unresponsive

Treatment Overview Mitomycin C bladder instillation is a targeted intravesical chemotherapy treatment used for non-muscle invasive bladder cancer (NMIBC). In this procedure, the anti-cancer drug

Treatment Overview Bacillus Calmette-Guérin (BCG) therapy is a cornerstone immunotherapy for non-muscle invasive bladder cancer (NMIBC). It involves instilling a weakened strain of Mycobacterium bovis

Treatment Overview Intravesical chemotherapy is a targeted treatment for bladder cancer, in which anti-cancer drugs are delivered directly into the bladder through a catheter. This